Saturday, November 27, 2021

NEWS

BioNTech seeks to increase vaccine manufacture

BioNTech seeks to increase vaccine manufacture

Berlin, Mar 31 (Prensa Latina) German BioNTech drugmaker informed that it plans to produce nearly 2.5 billion doses of its Covid-19 vaccine in 2021, which it is developing together with US Pfizer company.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

This increase will be achieved thanks to the process optimization, the network expansion and clearance to extract six doses from the same vial, the group explained in a statement.

Pfizer and BioNTech delivered over 200 million vaccines across the globe until March 23, 2021.

Last week’s approval of a new plant in Marbourg, in southern Germany, will support this increase.

Some 250 million doses will be produced in that place, which will start operation in mid-April, in the first six months of the year, and annual production will reach one billion doses.

This factory will be the second production center of the vaccine in Europe together with that in Puurs, Belgium. In addition, this vaccine is also produced in three plants in the United States.

rly/aph/mgt/rfc

RELATED
ÚLTIMO MINUTO
name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.